MAIA Stock Analysis: Buy, Sell, or Hold?
MAIA - MAIA Biotechnology, Inc.
$1.34
0.02 (1.52%)
▲
5d:
+8.06%
30d:
-8.22%
90d:
-3.6%
HOLD
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 10, 2026
5d
Get Alerted When MAIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MAIA trades at premium valuation expecting 11.8% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: MAIA trades at premium valuation expecting 11.8% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.26
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MAIA is currently trading at $1.34, which is considered fair relative to its 30-day fair value range of $1.27 to $1.45. From a valuation perspective, the stock is trading at a premium (Forward PE: 1.2) compared to its historical average (0.8). At these levels, the market is pricing in 11.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MAIA is in a strong downtrend. The price is approaching resistance at $1.35. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MAIA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.13 (+819.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MAIA is in a strong downtrend. The price is approaching resistance at $1.35. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MAIA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.13 (+819.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.27 -
$1.45
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 819.3% below Wall St target ($12.13)
- NEUTRAL: Trading at premium valuation - market expects 11.8% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$1.27 -
$1.45
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.19
Resistance Level
$1.35
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.18
Wall Street Target
$12.14
(+819.3%)
Valuation Premium vs History
+11.8% premium
PE vs Historical
1.2 vs 0.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.8%
(market-implied from PE analysis)
1-Year Target
$1.48
(+12%)
2-Year Target
$1.65
(+25%)
3-Year Target
$1.84
(+40%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
PE COMPRESSION
$1.25
(-5%)
Significant PE compression expected
Share & Embed Analysis
Last updated: August 04, 2026 12:19 PM ET
Data refreshes hourly during market hours. Next update: 1:19 PM
Data refreshes hourly during market hours. Next update: 1:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAIA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 51 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 52 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
